The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Featured Articles
About Us
Articles
-
-
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
-
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
-
The era of cryptic exons: implications for ALS-FTD
-
Deficits in mitochondrial TCA cycle and OXPHOS precede rod photoreceptor degeneration during chronic HIF activation
-
The neuropathological diagnosis of Alzheimer’s disease
-
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
-
Drosophila melanogaster as a model organism for Alzheimer’s disease
Current Thematic Review Series
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde. The collection can be read here.
ISMND Science Webinar Series 2023
Introducing the ISMND Science Webinar Series! The next speaker will be Professor Sir John Hardy, Ph.D., M.D.(Hons), Chair of Molecular Biology of Neurological Disease at the UCL Queen Square Institute of Neurology.
Talk title: Genomic analysis of neurodegenerative disease reveals commonalities between them and point the way towards therapies.
Date: Thursday, April 13, 2023
Time: 11-12:30 pm Eastern Standard Time
Free Registration: http://bit.ly/3mYB7sz
News from Alzforum
Article collections
New collection:
Glial and Vascular Contributions to Neurodegenerative Diseases
Edited by: Robert Vassar and Hui Zheng
Past collections:
ALS: Challenges and New Advances
Alzheimer's Disease: Challenges for the next decade
Parkinson's Disease - A Series of Reviews
Novel Systems and Emerging Concepts
Basic biology and disease pathways
In commemoration of Huaxi Xu
It is with a heavy heart that Springer Nature and Molecular Neurodegeneration say farewell to our long-serving co-Editor-in-Chief, Dr. Huaxi Xu. On October 14, 2022, Dr. Xu passed away after his brave battle against cancer, leaving behind a legacy of groundbreaking research in neurodegenerative disease, exemplary editorship, and undeniable leadership.
Follow
Annual Journal Metrics
-
Citation Impact
18.879 - 2-year Impact Factor (2021)
15.024 - 5-year Impact Factor (2021)
2.702 - Source Normalized Impact per Paper (SNIP)
4.731 - SCImago Journal Rank (SJR)Speed
20 days to first decision for all manuscripts (Median)
54 days to first decision for reviewed manuscripts only (Median)Usage
1,034,660 downloads (2021)
1,462 Altmetric mentions (2021)
Contact the Managing Editorial Team
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline